early

Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease in the New England Journal of Medicine

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s... » read more

Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market

HONG KONG, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Colorectal cancer (CRC) has become one of the main cancers threatening the health of human beings. In the United States and China, CRC has ranked among the top three cancers that leads to death. CRC screening has been proven to be one of the... » read more

New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82%

HANGZHOU, Aug 19, 2022 – (ACN Newswire via SEAPRWire.com) – New Horizon Health (6606.HK), China’s leading biotechnology company for early cancer screening, announced its half-year results for the year ended June 30, 2022 today. Based on the financial information before the audit as of June 30, 2022, New Horizon Health achieved total revenue of RMB226... » read more

Eisai Publishes Potential Economic Value of Investigational Lecanemab in Peer-Reviewed Neurology and Therapy Journal

TOKYO, Jun 22, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. today announced publication of results from an early phase evaluation that aimed to estimate potential economic value of its investigational anti-amyloid-beta (Abeta) protofibril antibody lecanemab in people living with early Alzheimer’s disease (AD) using a validated disease simulation model, AD Archimedes Condition... » read more

Eisai to Present New Lecanemab Data Exploring Distinct Mechanism of Action and Clinical Outcomes, Disease State (DSE) Symposium, and Other Pipeline Assets at the AD/PD 2022 Annual Meeting

TOKYO, Mar 11, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today the company will present research from its robust Alzheimer’s disease (AD) pipeline, including the latest findings on lecanemab, Eisai’s investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of early AD at the AD/PD 2022 International Conference on Alzheimer’s and... » read more

Investigational Alzheimer’s Disease Therapy Lecanemab Granted FDA Fast Track Designation

TOKYO, Dec 24, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that lecanemab, an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of early Alzheimer’s disease (AD), was granted Fast Track designation by the U.S. Food and Drug Administration (FDA). FDA granted Breakthrough Therapy designation for lecanemab... » read more

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

SYDNEY, Oct 14, 2021 – (ACN Newswire via SEAPRWire.com) – Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment program designed to keep the invention Australian owned – while rolling out treatment to the world. Prof Thomas Borody – Topelia announces US$25 mil Series... » read more

Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer’s Disease Under the Accelerated Approval Pathway

TOKYO, Sep 28, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. today announced that Eisai has initiated a rolling submission to the U.S. Food and Drug Administration (FDA) of a Biologics License Application (BLA) for lecanemab (BAN2401), the company’s investigational anti-amyloid beta (Abeta) protofibril antibody, for the treatment of early... » read more

Football: Centurion Lukaku sets Belgium on their way to convincing win over Czechs

BRUSSELS (REUTERS) – Romelu Lukaku marked his 100th cap with an early goal to set Belgium on their way to an impressive 3-0 win over the Czech Republic in their World Cup qualifier in Brussels on Sunday (Sept 5). It was Lukaku’s 67th goal for his country and came after eight minutes, followed by a... » read more

Queues form early for free masks on morning of Temasek Foundation’s fifth distribution exercise

SINGAPORE – People began queueing for free masks early on Thursday morning (Aug 26) as Temasek Foundation kicked off its fifth Stay Prepared initiative. Each household can collect 50 medical-grade surgical masks and 25 N95 respirator masks at selected malls and supermarket outlets islandwide from Thursday to Sept 26. The exercise was announced earlier this... » read more

New Horizon Health Announces 2021 Interim Results: Revenue Increases 317% Year-on-year, Gross Profit Margin Climbs to 56.2%

HANGZHOU, Aug 21, 2021 – (ACN Newswire via SEAPRWire.com) – New Horizon Health (6606.HK) (the “Company”), the first public listed cancer screening company in China, has today announced its financial report for the first half year ended 30 June 2021. In the first half of 2021, the Company’s total revenue was RMB43.9 million, a year-on-year... » read more

Early childhood pilot programme KidStart grows to become non-profit entity

SINGAPORE – A successful early childhood pilot programme that provides support to children from low-income homes has expanded so rapidly that it is now registered as a not-for-profit company. KidStart joins the ranks of other such government-linked companies limited by guarantee (CLG) in Singapore such as SG Enable, which delivers programmes for those with disabilities,... » read more

Singapore’s move to integrate pre-schools with early intervention support welcomed

SINGAPORE – Four times a week, Madam Pathmaranee Kumorsamy shuttles her five-year-old son, who has autism, from his early intervention centre to his pre-school. Having to travel between the two places tires him out, and he is able to attend only a short two hours at the PAP Community Foundation (PCF) Sparkletots pre-school, said Madam... » read more

Despite early doubts, former nurse finds success working in pre-school

SINGAPORE – The sight and sound of infants laughing are among the reasons Ms Jacintha Jayadas looks forward to her work as an early childhood educator. The 27-year-old said even on weekends, when she is off, she misses the children. Ms Jacintha, who is single, now works at Tots and Teddies in Telok Ayer, after... » read more

Kindergarten principal has no regrets giving up architecture five years ago

SINGAPORE – When 33-year-old Eudora Tan made the switch to early childhood education from architecture five years ago, there were many people who questioned her decision. She had spent five years studying to be an architect at the National University of Singapore, including completing a master’s degree. “To them, architecture seemed like a profession that... » read more

DETAK by Brawijaya University Researchers detects Heart Disease Early and Accurately

Malang, East Java, Indonesia, Nov 27, 2020 – (ACN Newswire) – Researchers from the Brawijaya University (UB) Medical School in Malang, East Java have developed DETAK, a smartphone application for patients with heart disease. The app works on an AI (artificial intelligence) algorithm, to provide early and accurate detection of heart disease, or acute coronary... » read more

Blood test for early detection of gastric cancer being evaluated for use in primary healthcare

SINGAPORE – A blood test that can detect gastric cancer in its early stages has been developed and is currently being evaluated for use in hospitals and clinics, said the National University Health System (NUHS) on Friday (Oct 23). In Singapore, gastric cancer is the fifth cause of cancer deaths in men and the sixth... » read more